Ridgetech Completes Capital Restructuring with Share Subdivision

Ridgetech ( (RDGT) ) has shared an announcement.

On May 28, 2025, Ridgetech, Inc. completed a significant capital restructuring involving a capital reduction and share subdivision, following approval at its annual general meeting on February 25, 2025. The par value of each issued ordinary share was reduced from US$0.24 to US$0.001, and each authorized but unissued ordinary share was subdivided into 240 new shares. This restructuring, confirmed by the Grand Court of the Cayman Islands, resulted in an authorized share capital of US$36,010,000, divided into 36 billion ordinary shares and 10 million preferred shares, both with a par value of US$0.001 each. This move aims to enhance the company’s financial flexibility and market positioning.

Spark’s Take on RDGT Stock

According to Spark, TipRanks’ AI Analyst, RDGT is a Underperform.

China Jo-Jo Drugstores is currently facing significant financial challenges, with negative profitability, high leverage, and declining cash flows being the primary concerns. Technical indicators also suggest a bearish outlook, with the stock trading below key moving averages. The valuation is unattractive due to negative earnings and the absence of a dividend. Overall, the stock is rated low, reflecting the need for strategic improvements to address financial instability and restore investor confidence.

To see Spark’s full report on RDGT stock, click here.

More about Ridgetech

Ridgetech, Inc., formerly known as China Jo-Jo Drugstores, Inc., is a Cayman Islands exempted company with its principal executive offices located in Hangzhou City, China. The company operates within the technology sector, focusing on providing innovative solutions and services.

Average Trading Volume: 84,653

Technical Sentiment Signal: Strong Sell

Current Market Cap: $6.02M

Find detailed analytics on RDGT stock on TipRanks’ Stock Analysis page.